Correlation Between Viridian Therapeutics and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Novo Nordisk AS, you can compare the effects of market volatilities on Viridian Therapeutics and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Novo Nordisk.

Diversification Opportunities for Viridian Therapeutics and Novo Nordisk

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Viridian and Novo is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Novo Nordisk go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Novo Nordisk

Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 2.15 times more return on investment than Novo Nordisk. However, Viridian Therapeutics is 2.15 times more volatile than Novo Nordisk AS. It trades about 0.03 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.02 per unit of risk. If you would invest  1,871  in Viridian Therapeutics on August 27, 2024 and sell it today you would earn a total of  149.00  from holding Viridian Therapeutics or generate 7.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Novo Nordisk AS

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Viridian Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Viridian Therapeutics and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Novo Nordisk

The main advantage of trading using opposite Viridian Therapeutics and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind Viridian Therapeutics and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA